A NEW METHOD OF IMMUNOTHERAPY OF SEVERAL KINDS OF TUMOR BLOOD DISEASES SUCH AS Acute Myeloid Leukemia (AML)

摘要

The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated cytotoxic peptide T-cell epitopes (CTLs), alone or in combination with other tumor-associated peptides, which serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several new peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells, which can be used in vaccine compositions for eliciting anti-tumor immune responses.